138 related articles for article (PubMed ID: 35703962)
1. Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II.
Ramiscal JAB; Stern SL; Wilson AK; Lorimer PD; Lee NA; Goldfarb MR; Foshag LJ; Fischer TD
J Am Coll Surg; 2022 Jul; 235(1):49-59. PubMed ID: 35703962
[TBL] [Abstract][Full Text] [Related]
2. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
[TBL] [Abstract][Full Text] [Related]
3. Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas.
Jackett LA; Satgunaseelan L; Roper E; Lo SN; Thompson JF; Scolyer RA
Pathology; 2022 Feb; 54(1):71-78. PubMed ID: 34392983
[TBL] [Abstract][Full Text] [Related]
4. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
Mills JK; White I; Diggs B; Fortino J; Vetto JT
Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
[TBL] [Abstract][Full Text] [Related]
5. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
[TBL] [Abstract][Full Text] [Related]
6. The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma.
Egnatios GL; Dueck AC; Macdonald JB; Laman SD; Warschaw KE; DiCaudo DJ; Nemeth SA; Sekulic A; Gray RJ; Wasif N; Pockaj BA
Am J Surg; 2011 Dec; 202(6):771-7; discussion 777-8. PubMed ID: 22000117
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
8. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity.
Leong WL; Ghazarian DM; McCready DR
J Surg Oncol; 2003 Mar; 82(3):143-6. PubMed ID: 12619055
[TBL] [Abstract][Full Text] [Related]
9. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck.
May MM; Lohse CM; Moore EJ; Price DL; Van Abel KM; Brewer JD; Janus JR
Int J Dermatol; 2019 Oct; 58(10):1184-1190. PubMed ID: 30968948
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
Kang JC; Wanek LA; Essner R; Faries MB; Foshag LJ; Morton DL
J Clin Oncol; 2005 Jul; 23(21):4764-70. PubMed ID: 16034052
[TBL] [Abstract][Full Text] [Related]
11. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
12. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
13. Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.
Hocevar M; Dragonja Z; Pilko G; Gazic B; Zgajnar J
Eur J Surg Oncol; 2014 Oct; 40(10):1271-5. PubMed ID: 24656456
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma.
Mangold AR; Skinner R; Dueck AC; Sekulic A; Pockaj BA
Dermatol Surg; 2016 May; 42(5):646-52. PubMed ID: 27082057
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in melanoma: final results of MSLT-I.
Durham AB; Wong SL
Future Oncol; 2014 May; 10(7):1121-3. PubMed ID: 24947251
[TBL] [Abstract][Full Text] [Related]
17. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis.
Knackstedt TJ
J Am Acad Dermatol; 2023 Apr; 88(4):848-855. PubMed ID: 36368376
[TBL] [Abstract][Full Text] [Related]
18. Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients.
Starz H; Balda BR
Int J Cancer; 2007 Aug; 121(3):689-93. PubMed ID: 17397029
[TBL] [Abstract][Full Text] [Related]
19. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
20. Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older.
Sabel MS; Kozminski D; Griffith K; Chang AE; Johnson TM; Wong S
Ann Surg Oncol; 2015 Jul; 22(7):2112-9. PubMed ID: 25834993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
